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Analyses of drug advertising reveal important social and cultural values and attitudes at a certain point 
in history. The purpose of this paper was to investigate how pharmaceutical industry communicates with 
pharmacists in Brazil, using drug promotion as a valuable tool. The point of departure was the analysis of 
a series of drug advertisements published in three Brazilian technical journals targeted at pharmacists and 
other health professionals. For the present study, the focus was on the content of the messages directed 
to pharmacists, in order to critically analyze the role attributed to these professionals as portrayed by 
the ads, and to discuss it in the context of pharmaceutical care. The collection and analysis of the data 
followed Anvisa’s methodology. Pharmacists’ social responsibility includes the reduction of preventable 
drug-related morbidity and mortality, but the information provided by the ads only refers to sales growth 
and profitability. Pharmacists are portrayed as salesmen, rather than health professionals, and encouraged 
to sell pharmaceutical drugs which are being heavily advertised to medical doctors. Consequences for 
pharmaceutical care are discussed. 
Uniterms: Drugs/advertising. Pharmacists. Pharamceutical care.
Análises de propaganda de medicamentos revelam importantes valores socioculturais e atitudes em um 
determinado contexto histórico. O objetivo deste trabalho foi analisar como a indústria farmacêutica se 
comunica com os farmacêuticos no Brasil, tendo a promoção farmacêutica como instrumento. O ponto de 
partida foi a análise de uma série de propagandas de medicamentos publicadas em três revistas técnicas 
dirigidas a farmacêuticos e outros profissionais de saúde. Para o presente estudo, o foco foi no conteúdo 
linguístico das mensagens, a fim de possibilitar uma reflexão crítica sobre o papel dos farmacêuticos no 
contexto da assistência farmacêutica, a partir das mensagens veiculadas pelos anúncios. A coleta e análise 
dos dados seguiu metodologia proposta pela Anvisa. A responsabilidade social dos farmacêuticos engloba 
a redução de morbidade e mortalidade relacionadas ao uso de medicamentos, mas os resultados mostram a 
ausência das informações necessárias à prática de uma atenção farmacêutica de qualidade. As informações 
divulgadas pelas propagandas referem-se basicamente ao aumento de vendas e de lucros. Longe de serem 
considerados profissionais da saúde, os farmacêuticos são retratados como meros vendedores. Além 
disso, são estimulados a vender os medicamentos que estão sendo extensamente propagandeados junto 
aos médicos prescritores. Discutem-se as consequências para a assistência farmacêutica. 
Unitermos: Propaganda de medicamentos. Farmacêuticos. Assistência farmacêutica.
INTRODUCTION
Analyses of drug advertisements reveal important 
social and cultural values and attitudes produced by and 
influencing societies at a certain point in history. Gomes 
(2006), for instance, investigated images of old drug 
ads as a valuable source for the history of medications 
in Brazil. Huertas and Campomar (2008) analyzed an 
advertisement of a prescription weight loss drug in order 
to understand the consumers’ perspectives toward medi-
cations, as well as their attitude and behavior in response 
to direct-to-consumer advertising. Other researchers 
have discussed the strategies used by the pharmaceutical 
industry to maximize profits through marketing efforts, 
including the redefinition of diseases to increase the 
number of patients and the reduction in thresholds for 
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therapy, in order to expand their markets (e.g., Sillup; 
Porth, 2008). Disease mongering in drug promotion is be-
ing discussed by several researchers, such as Moynihan, 
Heath and Henry (2002), Moynihan and Henry (2006) 
and Mintzes (2006).
Advertising messages vary according to the target 
audience and to the kind of product to be sold. Inohara 
(2005) discussed the four basic kinds of strategies: the 
informative, the persuasive, the comparative and the re-
minder advertisements, which can be used isolatedly or 
in various combinations, depending on the desired goal. 
And drug advertising and marketing is acknowledged 
as one of the factors which do influence consumption of 
pharmaceutical products.
Studies on drug advertising directed to prescribing 
physicians – the main target of drug promotion – have 
been extensively published. They confirm that this is not 
a reliable source of information for lay people, nor for 
health professionals. Brazilian studies on the quality of 
information given to medical doctors show that all ad-
vertisements are made in order to increase sales, omitting 
or neglecting important data on contraindications, side 
effects, risks, and other warnings (Pizzol, Silva, Schen-
kel, 1998; Barros, Joany, 2002; Mastroianni, Galduróz, 
Carlini, 2003; Nascimento, 2003; Luchessi et al., 2005; 
Soares, Lasmar, Figueiredo, 2005; Wzorek et al., 2007; 
Mastroianni et al., 2008; Soares, 2008). These data agree 
with international studies which have been developed for 
decades as well. 
But, so far, analyses of drug ads targeted specifically 
at pharmacists have not received the same attention in the 
literature. One study was found, in Portugal, by Galhardo 
(2006). The author analyzed the way the linguistic com-
ponents of drug ads communicate with pharmacists, the 
mediators between the producer and the final consumer. 
Her research on ads published in Farmácia Distribuição, a 
Portuguese journal, showed that the messages intend not 
only to make pharmacists informed about the drugs, but to 
encourage them to recommend the products to their clients. 
In Brazil, our regulatory authority, the National 
Agency for Health Surveillance (Anvisa), started a na-
tional project for monitoring advertising and publicity of 
products under health surveillance in 2002, working in 
partnership with almost 20 universities all over the country 
(Brasil, 2002). The MonitorAÇÃO Project at Fluminense 
Federal University (UFF) was coordinated by this au-
thor. For one year, almost 200 drug advertisements were 
analyzed from pharmacotherapeutic, legal and linguistic 
points of view, by students from different graduation 
courses (Soares, 2005; Soares, 2008).
In 2005, during the MonitorAÇÃO Project, 10 drug 
ads published in Guia da Farmácia were analyzed. The 
messages directed to pharmacists were explicit on their 
purely commercially-driven content, seriously infringing 
Brazilian legislation. The analyses were then sent to An-
visa, so that the legal and necessary interventions could be 
made (Soares, 2005). We considered important to continue 
collecting data on this specific kind of advertising. Thus, 
the main purpose of this paper was to investigate how 
pharmaceutical industry communicates with pharmacists 
in Brazil, using drug promotion as a valuable tool. The 
point of departure was the analysis of a series of drug 
advertisements published in three Brazilian technical 
journals targeted at pharmacists and other health profes-
sionals. For the present study. we focused on the content 
of the messages directed to pharmacists, in order to criti-
cally analyze the role attributed to these professionals as 
portrayed by the ads, and to discuss it in the context of 
pharmaceutical care. A similar version of this article was 
the basis for an oral communication presented at The Third 
International Conference The Pharmaceutical Lifecycle 
(Soares, 2009).
MATERIAL AND METHODS
The journals reviewed were Revista ABCFARMA, 
K@iros, and Guia da Farmácia, all published monthly and 
directed to health professionals, particularly to pharma-
cies’ staff. They are mainly distributed to private phar-
macies in Brazil. The issues were obtained through the 
contact with pharmacists working at private community 
pharmacies in Niterói and in Rio de Janeiro. The time 
range was from June 2005 to June 2008.
The methodology of data collection and analysis 
was defined by Anvisa (Brasil, 2005). Five among the 10 
drug advertisements published in Guia da Farmácia first 
analyzed in 2005 were reviewed for the present study. 
Moreover, the research was expanded in order to check 
if this pattern of advertising strategy could also be found 
in other journals distributed to pharmacies, as well as to 
investigate if there were any changes since 2005. The main 
results are presented and discussed below.
Considering that words and images play an essen-
tial role in the information, manipulation or publicity of 
products or ideas, the analyses focused on the linguistic 
content of the messages and on the images displayed in 
drug advertisements which were specifically targeted at 
pharmacists. The ads were chosen so that they could illus-
trate the main purposes of marketing campaigns portrayed 
in the different journals.
As the study was limited to drug advertisements 
analysis, no ethical approval was required.
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TABLE I - Information about the journals analyzed





Guia da Farmácia Sept. 2005 125 61 48.8 37 29.6
Guia da Farmácia Dec. 2005 93 42 45.2 21 22.6
Guia da Farmácia May 2006 134 60 44.8 41 30.6
K@iros May 2005 76 47 61.8 31 40.8
ABCFARMA Sept. 2005 92 49 53.3 30 32.6
ABCFARMA May 2008 88 51 57.9 28 31.8
ABCFARMA June 2008 92 46 50 26 28.2
Average 100 51 31
RESULTS
Table I describes the technical journals. The issues of 
Guia da Farmácia containing the drug ads first analyzed 
during the MonitorAÇÃO Project had to be sent to Anvisa, 
due to legal demands. Therefore, those issues were not 
included in the table.
Sample of drug ads first analyzed in 2005
FEMINA® – Collected on Aug. 10, 2005; published 
in Guia da Farmácia 151, June 2005. Desogestrel and ethi-
nyl estradiol, oral contraceptive, prescription drug (Rx).
The aims of the message were to inform about the 
new package, with reduced number of tablets, and to en-
courage pharmacists to order the product.
Headline: “The package of Femina was reduced so 
that your sales continue to grow.”
Other information: “Big promotional campaign with 
the force of Aché’s representatives. Order now.”
The image shows a beautiful woman, hair and 
clothes in the wind, creating a very light and relaxed 
atmosphere.
BUSCOPAN® – Collected on Aug. 10, 2005; pub-
lished in Guia da Farmácia 151, June 2005. Scopolamine 
butylbromide, anticholinergic, over the counter (OTC). 
The aim of the advertising message was to expand 
the target population of consumers, to include men, as 
this is a very popular product among women. The ad also 
encourages pharmacists to sell it.
Headline: “Double your profits: men also have 
colic.”
Other information: “Increase sales with Buscopan. 
Ideal for men, women and your income.”
“Always have Buscopan in your pharmacy.”; “It’s 
fast. It’s effective. It’s Buscopan.”
The image highlights the different pharmaceutical 
presentations of the product. The green and yellow colors 
of the product are displayed in the background.
SORINE® – collected on Aug. 10, 2005, published in 
Guia da Farmácia, 151: 49, June 2005. Sodium chloride 
+ benzalkonium chlorhydrate, topical nasal decongestant, 
OTC.
The aim of the advertising message was very clear: 
to explain the marketing strategies used to seduce the 
population, so that pharmacists can play their role: be 
ready for the increased sales of the product. 
As it is a topical nasal decongestant, there is a game 
of words with congestion as a medical event and conges-
tion of people. The analysis showed that the information 
about adverse reactions, warnings and contraindications 
were omitted.
Headline: “Congestion? Only at your point of sale.”
Other information: “Prepare your stock of Sorine 
infantil [for children]. There will be congestion at your 
point of sale.”; “Sorine infantil was launched on TV 
with the winning advertising ‘Congestion’, besides the 
POS materials, merchandising and ads on the main 
magazines”.
The image displays the product with a relaxing light 
blue background.
ANADOR® – Collected on Aug. 10, 2005; published 
in Guia da Farmácia 151: 59, June 2005. Sodium dipy-
rone, analgesic, OTC.
The aim of the advertising message was to make 
pharmacists buy the product in order to have it for sale in 
the pharmacy. No need for therapeutic information: ad-
verse reactions, warnings and precautions were omitted, as 
well as dosage. Contraindications were partially informed, 
and on a separate place in the journal.
Headline: “The consumer who does not find Anador 
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will always look for it at another pharmacy. Do you see 
the damage a headache can cause?”
The image displays a drawing of a human figure, 
with a big smile and Anador pills as its eyes.
FLOGORAL® – Collected on Aug. 10, 2005; pub-
lished in Guia da Farmácia 151, June 2005. Benzydamine 
hydrochloride, nonsteroidal anti-inflammatory (NSAID), 
OTC.
The aim of the message was to announce the launch-
ing of a new advertising campaign.
Headline: “A great campaign in order not to leave 
doubts in consumers’ minds, nor Flogoral on the gon-
dola.”
Other information: “Flogoral will be everywhere 
this winter. The big 2005 campaign will bring insertions 
and TV shows sponsorship, besides the greatest investment 
on POS in the history of the product. Prepare your stock. 
Flogoral is effective at treating throat problems, and a 
specialist at raising your sales”. 
The images shows different ways to display the 
product, as well as logos of the TV channels where the 
campaign will be inserted.
Sample of new analyses of drug advertisements 
targeted at pharmacists
SIBUTRAMINA® – ABCFARMA, 201: cover, May 
2008. Sibutramine, appetite suppressant, Rx, generic 
product.
The aim of the advertising message was to encour-
age the dispensing of this generic product.
Sales argument: the promise of a benefit (increased 
sales). There is a game of words with prescription and 
recipe. In Portuguese, both words can be used to refer to 
a prescription.
Headline: “Sibutramina Medley. When you dispense 
this prescription, it becomes a recipe for good business”. 
Other sentences: “Sibutramine: leader of prescrip-
tions and sales”. 
Aim of the image: to encourage pharmacists to have 
the product in the pharmacy, because medical prescriptions 
are being filled out. 
CLARITIN® – K@iros, 198: 7, May 2005. Lorata-
dine, antihistamine drug.
The aim was to advertise that the product had 
changed from Rx to OTC.
Headline: “With such a package, do you think we 
would be hiding behind the counter?”
Other sentences: “New package, no red stripe and 
now available for self service.” “Good for the clients, 
better for your sales”. “Claritin. More freedom, to make 
you breathe easily.”
No information on therapeutic data. 
The aim of the image was to show that the product 
had changed from Rx to OTC, implying more freedom to 
sell it. A new package, with new colors; the goal was to 
distinguish it from the previous package, which was red 
and had the red stripe obligatory in Rx products. The blue 
background matches the blue package... with a green field, 
reminding of freedom, as the sale is not linked to a pre-
scription anymore! This open space also relates to the fact 
that the product can be more exposed now that it is OTC.
SLENFIG® – ABCFARMA, 202:39, June 2008. 
Sibutramine hydrochloride, appetite suppressant, Rx. 
Headline: “SLENFIG/ sibutramine”.
Other sentences: “The slim figure recipe: 
·	 accessible price, which encourages clients' loyalty;
·	 aggressive brand exposure in medical practices and 
scientific journals all over Brazil;
·	 intense promotional investment on 30,000 physi-
cians."
"Slenfig is the recipe for the slim figure and the em-
bodied cashbook."
Technical information in very small font.
Aim of the image: a happy and slim woman, remind-
ing the logo and the consequences of Slenfig’s consump-
tion.
LEVCIN® – ABCFARMA, 201:29, May 2008. Levo-
floxacin, antibacterial agent, Rx.
Aim of the advertising message: to launch this new 
product and to reinforce the sales slogan “simple and 
fast”. These words are repeated in several places. Sales 
argument: the promise of a benefit (simple and fast to sell).
Headlines: “Levcin, levofloxacin. Simple as that. 
Fast as that.”
“Launching with support from medical visitation 
staff.”
Other sentences: “The prescription is made by the 
doctor. Simple as that.”
“The patient comes to your pharmacy. Fast as that.” 
“Get ready to supply Levcin!”
“The treatment is simple and fast.” 
There is the image of a physician, a reminder note 
that doctors will be visited, and several boxes of the prod-
uct. Technical information in very small font.
FLUTICAN® – ABCFARMA, 201:7, May 2008. 
Fluticasone propionate, synthetic corticosteroid, Rx.
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This is an example of a seasonal product advertis-
ing campaign. The aim was to remind the product. The ad 
has no technical information, but goes into details about 
the producer’s marketing strategies to reach prescribing 
physicians.
Headline: “FLUTICAN - fluticasone propionate”
“Glenmark Line of Respiratory Products”
“Take advantage of the pre-high and guarantee 
your winter!”
Other sentences: “aggressive sampling to physicians”
“Intense advertising for medical specialists”
“More than 3,500 otolaryngologists”
“More than 3,000 pneumologists and allergists.”
The image highlights the sentences and displays the 
product, in a light blue background.
VIAGRA® – Guia da Farmácia, 157: 38-9, Dec. 
2005. Double page. Sildenafil citrate, for erectile dysfunc-
tion, Rx.
The aim was to announce a new package of the 
product.
Headline: “V from vending more in your pharmacy”.
Other sentences: “Viagra, the greatest potency at 
the market. Now, package with 2 pills. Prepare your stock 
for increased sales”.
The image displays a hand with the “V” – from 
Viagra, Victory, Vending – and the new package of the 
product. Aim of the image: to encourage sales and to 
present the new package with two pills. The background 
is a black and white photograph, and the blue of Viagra is 
highlighted in the sentences, name of the laboratory and 
in the pills themselves.
HELLEVA® – ABCFARMA, 202: 69, June 2008. 
Lodenalfil carbonate, for erectile dysfunction, Rx.
Aim: to inform about a new product for erectile 
dysfunction.
Headline: “Our specialty is to put up… your busi-
ness”.
Other sentences: “Holographic seal and perforated 
package; more protection against fraud: more comfort 
and discreetness”; “Helleva has arrived. The most recent 
product for erectile dysfunction.” 
The name of the product (Helleva is very similar 
to Eleva, which means elevate, raise), the game of words 
and the use of a high tree highlighted among other ordi-
nary trees are explicitly related to the problem of erectile 
dysfunction. This advertisement was banned by Anvisa 
on June 29, 2009.
CORISTINA D® – K@iros, 198: 58-9, May 2005. 
Double page. Acetylsalicylic acid + dexchlorpheniramine 
+ phenylephrine + caffeine, OTC.
Aim: The use of TV stars is a very common strategy 
to publicize drugs. Here, there is a picture of Regina Casé, 
a very popular TV and film star in Brazil. The ad goes 
into details about the marketing strategies: the TV chan-
nels where the ad will be shown, the TV shows where the 
merchandising will appear, the promotional material that 
will be distributed to the pharmacies. The only technical 
information is on the contraindications, in very small font.
Headline: “Have you got Coristina d in your phar-
macy? Your sales will grow, huh?!”
Other information: “Coristina d is coming back to 
media with total force this winter”; “Reinforce your stock! 
Because your clients know that: Good against influenza is 
Coristina d. It is worth as much as 3.” 
POLARAMINE® – K@iros, 198: 38-9, May 2005. 
Double page. Dexchlorpheniramine maleate, antihista-
mine, OTC.
This was another example of a reminder campaign.
Headline: “Thought about selling, reminded of 
Polaramine”.
Other sentences: “Whenever your client thinks of 
allergy, he reminds of Polaramine. And now, more than 
ever! (…) A campaign to inform your clients about al-
lergy and Polaramine. Ads in magazines, merchandising 
in TV shows, radio communication in the main Brazilian 
capitals.”; “Reinforce your stock of Polaramine on the 
self-serving shelves and get ready to sell much more”. 
The image of a beautiful and happy child lying on a 
woolen pillow intends to show the benefits of this antial-
lergic product. But this drug should not be used in children 
under 2 years of age.
There are also images of the different packages 
of Polaramine, and a reminding message: “no stripe”, 
to remind that it is an OTC drug. Furthermore, there are 
pictures of covers of popular magazines and logos of the 
TV shows where the ads will be displayed.
QUEIMALIVE® – Guia da Farmácia, 157:21, 
Dec.2005. Sulfacetamide sodium + triethanolamine. OTC. 
Analgesic, antibiotic, emollient, healing.
Headline: “Queimalive. Heats up sales, without 
cooling off on the shelf.”
Other sentences: “analgesic, antibiotic, emollient, 
healing”; “Treatment of sunburns and domestic burns”; 
“Adult and pediatric uses”. 
It says: “Adults and pediatrics uses”, though the 
product should not be used in children under 12.
Queimalive is registered at Anvisa as a combination 
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product: triethanolamine/sulfacetamide sodium, indica-
tion: topical antiinfective agent. But in the ad, there are 
other therapeutic indications: analgesic, antibiotic, emol-
lient, healing. And the whole propaganda, including the 
name of the product – Queimalive refers to “burnrelief” 
– recommends the product for the treatment of sunburns 
and domestic burns.
The only technical information relates to contrain-
dication: “do not use it if you are allergic to sulfa or any 
ingredient of the formula and in breastfeeding women.”
Image: the background is the sun shining on the 
beach, and a sunshade protects the product, in an analogy 
to the product’s alleged therapeutic action.
DISCUSSION
The three journals contain a great amount of ad-
vertisements (51%, on average). Even considering only 
full-page advertisements, 31% of the journals’ content 
are, in fact, drug ads, thus suggesting their promotional 
goal. In her analysis of a monthly journal from Portugal 
– Revista Farmácia Distribuição – targeted at health pro-
fessionals, Galhardo (2006) found that 35% of the pages 
were full-page advertisements, the majority of which were 
drug ads. As it can be seen, her results are quite similar to 
our findings. Such pattern has also been found in medi-
cal journals published in Brazil. Barros and Joany (2002) 
studied all ads present in the issues of Jornal de Pediatria, 
Jornal Brasileiro de Medicina, and Revista Brasileira de 
Medicina from August 2000 to February 2001. A total of 
30.4% of the 1,774 pages reviewed were advertisements. 
In only about 20%, adverse reactions, contraindications, 
and interactions were mentioned. The authors concluded 
that the ads were tendentious, responding to commercial 
objectives, and should not be considered a source of infor-
mation for a good quality prescription, nor for the correct 
use of pharmaceuticals.
The critical part of a marketing campaign is de-
termining the theme to be exploited in the individual 
advertisements and other forms of communications. The 
theme is responsible for the whole tone of the campaign, 
as several strategies and media are used in order to reach 
out to the target audience and to communicate with the 
customers. There are different types of advertising ap-
peals but, in general, emotions are manipulated in order 
to achieve the advertising goals, and as little information 
as possible is given, especially in relation to unwanted 
aspects of the product.
Riera, Fuente and Rodriguez (2007) analyzed 
several characteristics of 195 drug advertisements in 
four Spanish medical journals of four different medical 
specialties. In relation to the advertising message, the re-
searchers evaluated five factors: communication aim, sales 
argument, communication treatment, and use of text and 
image. A total of 72.6% of the ads presented communica-
tion treatment, and the information was portrayed in quite 
a standardized way: a large headline, in order to attract the 
reader’s attention and to synthesize the sales arguments; 
a photo, which symbolically represented the product and 
promised a benefit; sales arguments and reinforcing argu-
ments as well. A slogan was also present in half of the ads. 
From the results obtained, the authors designed a fictitious 
drug advertisement (p. 376).
This pattern is quite similar to the one in our ads 
indeed. However, their sales arguments were 87% rational, 
based on efficacy (61%) and comfort/convenience (22%). 
In the ads portrayed in the present article, most sales argu-
ments were also rational, but based on marketing strate-
gies, pure advertising language, in order to explicit how 
pharmacists will make money with the products: “Heats 
up sales, without cooling off on the shelf”; “The package 
was reduced so that your sales continue to grow”. The ads 
also go into detail about the marketing strategies to be used 
with the physicians, in the case of Rx drugs, as seen in the 
ad for Flutican®, for instance. In the case of OTC products, 
the target group is the lay population. So: “A campaign to 
inform your clients about allergy and Polaramine. Ads in 
magazines, merchandising in TV shows, radio communica-
tion in the main Brazilian capitals.”
The vocabulary used is very limited, and the sen-
tences are short, simple and objective. This point also 
coincides with Galhardo’s findings. But, while in the 
Portuguese journal the messages also intended to make 
pharmacists informed about the products, in our case, the 
main information given was related to sales arguments and 
strategies. As seen above, in drug ads targeted at Brazilian 
pharmacists, very little information on therapeutic and 
technical data about the products was provided, infringing 
Brazilian legislation, which was basically the Anvisa’s 
Ruling 102/2000 at that time. 
The messages to pharmacists also differ from the 
ones directed to physicians, as seen in the studies men-
tioned above. Even if the information is neither complete 
nor of good quality, some technical information about 
the products is presented. This was observed in the Bra-
zilian studies developed by Pizzol, Silva and Schenkel 
(1998), Barros and Joany (2002), Mastroianni, Galduróz 
and Carlini (2003), Nascimento (2003), Luchessi et al. 
(2005), Soares, Lasmar and Figueiredo (2005), Wzorek et 
al. (2007), Mastroianni et al. (2008), Mastroianni, Noto 
and Galduróz (2008), Soares (2008). International stud-
ies, such as the ones by Mejía and Avalos (2001), Loke, 
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Koh and Ward (2002), Cooper et al. (2003), Riera, Fuente 
and Rodríguez (2007), presented similar results. As stated 
by Monnerat (2003), the study of advertising messages 
reveals not only linguistic contents, but cultural and his-
torical aspects, attitudes and values of a certain society. 
So, when drug makers communicate with pharmacists, 
informing only contents which are important to sales-
men, omitting all information which should be provided 
to health professionals, this message has an important 
and implicit meaning: pharmacists are not acknowledged 
for their relationship with patients seeking healthcare. 
Their role in pharmaceutical care does not seem to be 
considered.
As for the limitations of the present research, it must 
be stated that the samples discussed are not representative 
of all drug advertisements portrayed in the journals, and 
the results cannot be generalized. It must be also noted that 
more research must be developed in order to compare the 
present results with drug advertisements launched after 
the new Resolution by Anvisa, approved in 2008 (Brasil, 
2008), as a result of many debates which included the 
results presented by the advertising monitoring project. 
But, as evidenced by previous experience and re-
search, real and efficient changes do not come only as a 
consequence of new legislation. Other factors influencing 
the context of drug use must be dealt with as well, in an 
integrated approach. Even if the data presented here refer 
to the period 2005-2008, all the analyses developed on the 
quality of drug advertising have shown that, after RDC 
Anvisa 102/2000, the legal infractions continued to be 
present in over 90% of the ads, according to the results of 
Anvisa’s drug advertising monitoring project. This was 
discussed by Soares (2008), in her defense of the banning 
of drug advertising. Though limited because of the time 
passed, the empirical data presented here continue to be a 
valuable source for present and future analyses, from our 
point of view.
CONCLUSIONS
As it has been observed in several studies, Brazil-
ian pharmaceuticals’ market presents many problems. 
Although it is the biggest market in Latin America and 
the ninth greatest per capita consumer in the world, the 
access to the products is extremely unequal: around 20% 
of the population has no access at all, while 50% do not get 
what they need at the healthcare public system (Rozenfeld, 
2008). The economic and commercial dimension of drug 
use largely prevails: pharmaceuticals are consumer goods 
to be used by those who can afford them. Besides, the 
market is not well regulated, frauds are quite common, 
data on pharmaceuticals’ consumption in the country are 
not well known, just to mention some of the facts reported. 
According to the Brazilian College of Pharmacists, 
there were 122,915 pharmacists, and 72,480 pharmacies 
and drugstores in the country, in December 2008. Far from 
the recommendations by the World Health Organization 
− 1 pharmacy or drugstore to every 8,000 inhabitants −, 
this proportion is around 1:2,550 in Brazil. As there is no 
regulation concerning the establishment of new pharma-
cies, they are spread throughout the country without any 
planning. This excessive number is also motivated by the 
economic and commercial aspects of the activity. Although 
all pharmacies must have a responsible pharmacist, these 
professionals are not present in many cases; the distribu-
tion of bonuses to the employees as rewards according 
to the sales is quite frequent; most prescription drugs are 
sold without any prescription, with a daily exposure of the 
population to several risks.
In the Brazilian Consensus of Pharmaceutical Care, 
published in 2002, it is stated that pharmacists should 
direct their activities towards health education, pharma-
ceutical care, patient orientation, dispensation, etc (OPAS, 
2002). According to Vieira (2007), they should also play 
an important role in rational drug use promotion, and 
their participation in multidisciplinary teams adds value 
to health services and contributes to health promotion. 
But, at present, Brazilian pharmacists have a very small 
insertion in health professionals’ staff. Pharmaceutical 
training is still inadequate to the population’s needs. 
Studies on the role of pharmacists in the private pharma-
cies or in the public healthcare system confirm that these 
professionals are not acting in the interest of patients, of 
health promotion, nor of rational drug use, in our country. 
Private community pharmacies and drugstores are purely 
and simply commercial facilities, pharmaceuticals are con-
sumption goods and pharmacists’ work there are focused 
on commercial activities rather than on health promotion. 
In Brazilian public healthcare system, pharmaceutical 
care does not respond to society’s demands either (e.g., 
OPAS, 2001; Vieira, 2007; Rozenfeld, 2008; Araujo et al., 
2008). In the PAHO proposal for Pharmaceutical Care, a 
similar diagnosis of the Brazilian context was made: lack 
of social acknowledgement and a weak insertion in the 
multiprofessional healthcare staff; failures in pharmaceuti-
cal education, which is still excessively technically-driven 
and with weak training in the clinical area; gap between 
pharmaceutical education and the demands of private and 
public healthcare units; dissociation between economic 
and collective health interests, the first ones prevailing 
(OPAS, 2002). Oliveira et al. (2005) investigated the obs-
tacles to pharmaceutical care in Curitiba and concluded 
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that it is necessary to stimulate professional practice, 
mainly among students and recently graduated profes-
sionals, in order to overcome the existing problems. Vieira 
(2010) identified various failures in pharmaceutical care 
in the National Health System (SUS) as well.
In the present context, pharmacists are not socially 
acknowledged in Brazil. The drug advertisements targeted 
at pharmacists confirm this scenario. They do not provide 
the necessary information a pharmacist would need in 
order to practice good quality pharmaceutical care. On 
the contrary, they reinforce and encourage the role of 
pharmacists as mere salesmen. They are not portrayed as 
health professionals by the pharmaceutical industry. The 
advertising messages mostly “teach” pharmacists how 
to achieve sales growth and a better profitability. As evi-
denced by the material discussed above, they communicate 
with these professionals by means of the standard language 
used by advertising directed to suppliers, distributors and 
sellers, in which the main words are sale and money. They 
also emphasize and explicit the strategies used to attract 
prescribing doctors (Rx drugs) or the lay population (OTC 
drugs), so that pharmacists improve sales. 
The advertisements portrayed here disclose impor-
tant social, political and cultural aspects related to pharma-
cists’ attitudes and to pharmaceutical care in Brazil; they 
also reinforce the image and role of pharmacists as com-
mercially-driven professionals in our society. Therefore, 
they are important indicators for the urgent changes that 
are needed in this field. Furthermore, failures and breaches 
at Anvisa become evident too. This kind of research may 
contribute to the debate on pharmaceutical policy, as it 
discloses several obstacles to good quality pharmaceuti-
cal care and claims changes in pharmacists’ attitudes and 
practices. It is clear that, in spite of all the improvements 
achieved in the field of drug use in our country, there is still 
a long and complex way to go, which requires educational, 
investigative, managerial and regulatory interventions 
within an integrated approach. 
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